fulvestrant has been researched along with daidzin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, T; Nakajin, S; Nakazawa, H; Ohno, S; Shinoda, S; Toyoshima, S | 1 |
| Boue, SM; Bunnell, BA; Burow, ME; Elliott, S; Gimble, JM; Jiang, Q; Ohlstein, JF; Strong, AL; Wang, G; Zhang, Q; Zheng, S | 1 |
2 other study(ies) available for fulvestrant and daidzin
| Article | Year |
|---|---|
Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol; Estrogen Receptor Modulators; Flavonoids; Fulvestrant; Humans; Hydrocortisone; Isoflavones; Kinetics | 2002 |
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.
Topics: Adult Stem Cells; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Drug Evaluation, Preclinical; Estradiol; Female; Fulvestrant; Humans; Inhibitory Concentration 50; Isoflavones; Mesenchymal Stem Cells; Osteogenesis; Osteoporosis; Phytoestrogens; Receptors, Estrogen | 2014 |